Helpful upcoming webinars this week

Three more upcoming webinars this week will deal with (a) the work-up of men with prostate cancer prostate cancer who progress after first-line therapy (such as surgery, radiation, etc.); (b) whether Gleason 6 disease should really be defined as “prostate cancer”; and (c) an update on the most current information related to the evaluation and management of men with prostate cancer appropriate for active surveillance. … READ MORE …

Three helpful upcoming webinars

Three upcoming webinars deal with (a) the diagnosis and work-up of clinically significant forms of localized prostate cancer; (b) handling anxiety and related issues for men on active surveillance (AS); and (c) whether AS is appropriate for African Americans and others of African ethnicity. See below for details. … READ MORE …

Webinar 2 on “Active Surveillance & Beyond”

At the end of this month, on Tuesday, September 29, at 8:00-9:30 p.m. Eastern time (to be precise), there will be a second webinar in the series on the role of active surveillance in the management of favorable-risk forms of localized prostate cancer, coordinated by our good friend Howard Wolinsky and others. … READ MORE …

Webinar series on active surveillance

We have heard from Howard Wolinksy that he and others have been helping to put together a series of four webinars on different aspects of active surveillance (AS) for the management of favorable-risk prostate cancer. … READ MORE …

Newly diagnosed? Free webinar on Wednesday, October 11

Prostate Cancer International is conducting a series of free webinars for patients and caregivers in October, November, and December.  Next Wednesday, October 11th, at 2:00 p.m. Eastern Time, Jan Manarite will lead a webinar for newly diagnosed prostate cancer patients. … READ MORE …

Nutrition and prostate cancer — an educational webinar

On Monday evening, at 5:00 pm Pacific / 8:00 pm Eastern on July 31, AnCan will be offering an educational webinar with Greta Mcaire, RD, the resident Registered Dietitian at the UCSF Cancer Center. … READ MORE …